اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدPower Analysis in a SMART Design: Sample Size Estimation for Determining the Best Dynamic Treatment Regime
100
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Sequential, multiple assignment, randomized trial (SMART) designs have become increasingly popular in the field of precision medicine by providing a means for comparing sequences of treatments tailored to the individual patient, i.e., dynamic treatment regime (DTR). The construction of evidence-based DTRs promises a replacement to adhoc one-size-fits-all decisions pervasive in patient care. However, there are substantial statistical challenges in sizing SMART designs due to the complex correlation structure between the DTRs embedded in the design. Since the primary goal of SMARTs is the construction of an optimal DTR, investigators are interested in sizing SMARTs based on the ability to screen out DTRs inferior to the optimal DTR by a given amount which cannot be done using existing methods. In this paper, we fill this gap by developing a rigorous power analysis framework that leverages multiple comparisons with the best methodology. Our method employs Monte Carlo simulation in order to compute the minimum number of individuals to enroll in an arbitrary SMART. We will evaluate our method through extensive simulation studies. We will illustrate our method by retrospectively computing the power in the Extending Treatment Effectiveness of Naltrexone SMART study.
قيم البحث
اقرأ أيضاً
Assessing the relative merits of sportsmen and women whose careers took place far apart in time via a suitable statistical model is a complex task as any comparison is compromised by fundamental changes to the sport and society and often handicapped
by the popularity of inappropriate traditional metrics. In this work we focus on cricket and the ranking of Test match bowlers using bowling data from the first Test in 1877 onwards. A truncated, mean-parameterised Conway-Maxwell-Poisson model is developed to handle the under- and overdispersed nature of the data, which are in the form of small counts, and to extract the innate ability of individual bowlers. Inferences are made using a Bayesian approach by deploying a Markov Chain Monte Carlo algorithm to obtain parameter estimates and confidence intervals. The model offers a good fit and indicates that the commonly used bowling average is a flawed measure.
One of the main goals of sequential, multiple assignment, randomized trials (SMART) is to find the most efficacious design embedded dynamic treatment regimes. The analysis method known as multiple comparisons with the best (MCB) allows comparison bet
ween dynamic treatment regimes and identification of a set of optimal regimes in the frequentist setting for continuous outcomes, thereby, directly addressing the main goal of a SMART. In this paper, we develop a Bayesian generalization to MCB for SMARTs with binary outcomes. Furthermore, we show how to choose the sample size so that the inferior embedded DTRs are screened out with a specified power. We compare log-odds between different DTRs using their exact distribution without relying on asymptotic normality in either the analysis or the power calculation. We conduct extensive simulation studies under two SMART designs and illustrate our methods application to the Adaptive Treatment for Alcohol and Cocaine Dependence (ENGAGE) trial.
Exploratory spatial data analysis (ESDA) plays a key role in research that includes geographic data. In ESDA, analysts often want to be able to visualize observations and local relationships on a map. However, software dedicated to visualizing local
spatial relations be-tween multiple variables in high dimensional datasets remains undeveloped. This paper introduces gwpcorMapper, a newly developed software application for mapping geographically weighted correlation and partial correlation in large multivariate datasets. gwpcorMap-per facilitates ESDA by giving researchers the ability to interact with map components that describe local correlative relationships. We built gwpcorMapper using the R Shiny framework. The software inherits its core algorithm from GWpcor, an R library for calculating the geographically weighted correlation and partial correlation statistics. We demonstrate the application of gwpcorMapper by using it to explore census data in order to find meaningful relationships that describe the work-life environment in the 23 special wards of Tokyo, Japan. We show that gwpcorMapper is useful in both variable selection and parameter tuning for geographically weighted statistics. gwpcorMapper highlights that there are strong statistically clear local variations in the relationship between the number of commuters and the total number of hours worked when considering the total population in each district across the 23 special wards of Tokyo. Our application demonstrates that the ESDA process with high-dimensional geospatial data using gwpcorMapper has applications across multiple fields.
In many health domains such as substance-use, outcomes are often counts with an excessive number of zeros (EZ) - count data having zero counts at a rate significantly higher than that expected of a standard count distribution (e.g., Poisson). However
, an important gap exists in sample size estimation methodology for planning sequential multiple assignment randomized trials (SMARTs) for comparing dynamic treatment regimens (DTRs) using longitudinal count data. DTRs, also known as treatment algorithms or adaptive interventions, mimic the individualized and evolving nature of patient care through the specification of decision rules guiding the type, timing and modality of delivery, and dosage of treatments to address the unique and changing needs of individuals. To close this gap, we develop a Monte Carlo-based approach to sample size estimation. A SMART for engaging alcohol and cocaine-dependent patients in treatment is used as motivation.
Detection of interactions between treatment effects and patient descriptors in clinical trials is critical for optimizing the drug development process. The increasing volume of data accumulated in clinical trials provides a unique opportunity to disc
over new biomarkers and further the goal of personalized medicine, but it also requires innovative robust biomarker detection methods capable of detecting non-linear, and sometimes weak, signals. We propose a set of novel univariate statistical tests, based on the theory of random walks, which are able to capture non-linear and non-monotonic covariate-treatment interactions. We also propose a novel combined test, which leverages the power of all of our proposed univariate tests into a single general-case tool. We present results for both synthetic trials as well as real-world clinical trials, where we compare our method with state-of-the-art techniques and demonstrate the utility and robustness of our approach.
الأسئلة المقترحة
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
